Therapeutic murine monoclonal antibody
US5179019A · kind A · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 1990 |
| Grant date | Jan 12, 1993 |
| Priority date | — |
| Expiry date | Nov 21, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a monoclonal antibody which is broadly reactive with all normal human peripheral blood mononuclear cells and granulocyte, and to the hybridoma cell line which produces this monoclonal antibody. This monoclonal antibody is designated WM-65 and the hybridoma cell line is designated F56-1D5 (ECACC 89033001). This monoclonal antibody reacts with a previously unrecognized human leucocyte surface membrane antigen. The relative molecular mass of the antigen recognized by WM-65 is approximately 40-50 Kilodaltons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.